JNJ News and Press, Johnson & Johnson From 06/14/24

2024-06-14 17:53:40 ET Summary Vanguard Health Care ETF focuses on investing in successful healthcare companies with $20 billion in assets and a low expense ratio of 0.10%. Top holdings include Eli Lilly, UnitedHealth Group, and Johnson & Johnson, offering potential for growth...

2024-06-14 15:55:36 ET More on Bristol-Myers Squibb Company , Gilead Sciences, etc. Bristol-Myers Squibb: Move Investing Time Horizon To 2025, At Least Gilead Sciences, Inc. (GILD) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript) Bristol-Myers...

2024-06-14 11:23:25 ET More on Johnson & Johnson Johnson & Johnson: Market Will Regret The Overreaction Cancer victims seek court order to block J&J’s bankruptcy bid J&J in $700M settlement with states over marketing of talc products Jo...

TALVEY® (talquetamab-tgvs) demonstrates highly durable, longer-term responses in patients with relapsed or refractory multiple myeloma PR Newswire 24-month overall survival rate of 67 percent achieved with TALVEY ® 0.8 mg/kg biweekly dosing in the Phase 1/2 Monum...

2024-06-13 18:32:48 ET Summary Boston Scientific Corporation is outperforming its peers in the med-tech sector with exceptional growth driven by key products like Farapulse and Watchman. Farapulse and Watchman are well-appreciated drivers with significant upside, but other contrib...

2024-06-13 15:02:59 ET More on Xencor Seeking Alpha’s Quant Rating on Xencor Historical earnings data for Xencor Financial information for Xencor Read the full article on Seeking Alpha For further details see: Xencor to regain rights from J...

2024-06-13 14:03:52 ET Summary Contineum Therapeutics, Inc. PIPE-791 is being developed for the treatment of neuroinflammatory disorders like idiopathic pulmonary fibrosis and Progressive Multiple Sclerosis. The global idiopathic pulmonary fibrosis market size is projected to reac...

2024-06-12 17:45:04 ET Summary Kenvue (KVUE) was created as the result of a spinoff from Johnson & Johnson and encompasses the consumer side of the business. KVUE manages a wide array of products within each segment, but sales volume remains vulnerable to consumer spending. ...

2024-06-12 16:38:08 ET Johnson & Johnson (JNJ) Goldman Sachs 45th Annual Global Healthcare Conference Call June 12, 2024, 02:00 PM ET Company Participants Jennifer Taubert - Executive Vice President, Innovative Medicine John Reed - Executive Vice President, Innov...

2024-06-12 15:34:26 ET More on Johnson & Johnson Johnson & Johnson: Market Will Regret The Overreaction Johnson & Johnson (JNJ) Bernstein's 40th Annual Strategic Decisions Conference - (Transcript) Johnson & Johnson: Vital Signs Decent, A Compelling V...